Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.
about
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia ScreenSynergistic Research Between the Center of Arrhythmia Research and the Michigan Biology of Cardiovascular Aging at the University of Michigan.
P2860
Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Deficient cMyBP-C protein expr ...... S cell derived cardiomyocytes.
@en
type
label
Deficient cMyBP-C protein expr ...... S cell derived cardiomyocytes.
@en
prefLabel
Deficient cMyBP-C protein expr ...... S cell derived cardiomyocytes.
@en
P2093
P2860
P1476
Deficient cMyBP-C protein expr ...... S cell derived cardiomyocytes.
@en
P2093
Adam Helms
Andre Monteiro da Rocha
Carly Luzod
Gary D Smith
Guadalupe Guerrero-Serna
Mark Russell
Sergey Mironov
Sharlene M Day
Todd J Herron
P2860
P304
P356
10.1016/J.YJMCC.2016.09.004
P50
P577
2016-09-09T00:00:00Z